CA2219082A1 - Utilisation de composes de dihydrotestosterone pour traiter une dysfonction sexuelle chez l'homme - Google Patents
Utilisation de composes de dihydrotestosterone pour traiter une dysfonction sexuelle chez l'homme Download PDFInfo
- Publication number
- CA2219082A1 CA2219082A1 CA 2219082 CA2219082A CA2219082A1 CA 2219082 A1 CA2219082 A1 CA 2219082A1 CA 2219082 CA2219082 CA 2219082 CA 2219082 A CA2219082 A CA 2219082A CA 2219082 A1 CA2219082 A1 CA 2219082A1
- Authority
- CA
- Canada
- Prior art keywords
- dihydrotestosterone
- dht
- sexual dysfunction
- subject
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention décrit une méthode de traitement d'une dysfonction sexuelle chez un patient, consistant à élever les taux de dihydrotestostérone (DHT) chez un patient pour traiter efficacement ladite dysfonction sexuelle. Les méthodes de l'invention peuvent être utilisées dans le cadre d'un traitement prophylactique et/ou thérapeutique des dysfonctions sexuelles.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44072695A | 1995-05-15 | 1995-05-15 | |
US08/440,726 | 1995-05-15 | ||
US48747195A | 1995-06-07 | 1995-06-07 | |
US08/487,471 | 1995-06-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2219082A1 true CA2219082A1 (fr) | 1996-11-21 |
Family
ID=27032530
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2219082 Abandoned CA2219082A1 (fr) | 1995-05-15 | 1996-05-01 | Utilisation de composes de dihydrotestosterone pour traiter une dysfonction sexuelle chez l'homme |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0827405A2 (fr) |
AU (1) | AU5671496A (fr) |
CA (1) | CA2219082A1 (fr) |
WO (1) | WO1996036339A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
GB0409498D0 (en) * | 2004-04-28 | 2004-06-02 | Hunter Fleming Ltd | Transdermal steroid formulation |
AU2005239962B2 (en) | 2004-05-11 | 2011-07-07 | Eb Ip Lybrido B.V. | Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction |
EP1790343A1 (fr) | 2005-11-11 | 2007-05-30 | Emotional Brain B.V. | Compositions pharmaceutiques et leur utilisation pour le traitement des dysfonctions sexuelles chez la femme |
EP1925307A1 (fr) | 2006-11-03 | 2008-05-28 | Emotional Brain B.V. | Utilisation de 3-alpha-androstanediol pour le traitement des dysfonctions sexuelles |
-
1996
- 1996-05-01 WO PCT/US1996/006078 patent/WO1996036339A2/fr not_active Application Discontinuation
- 1996-05-01 AU AU56714/96A patent/AU5671496A/en not_active Abandoned
- 1996-05-01 EP EP96913887A patent/EP0827405A2/fr not_active Withdrawn
- 1996-05-01 CA CA 2219082 patent/CA2219082A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1996036339A3 (fr) | 1997-02-13 |
EP0827405A2 (fr) | 1998-03-11 |
WO1996036339A2 (fr) | 1996-11-21 |
AU5671496A (en) | 1996-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
McGINNIS et al. | Evidence for a role of testosterone-androgen receptor interactions in mediating masculine sexual behavior in male rats | |
Martini | The 5α-reduction of testosterone in the neuroendocrine structures. Biochemical and physiological implications | |
Chahal et al. | The endocrine system and ageing | |
Casper et al. | Aromatase inhibitors for ovulation induction | |
Simon et al. | Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women | |
Gonzalez et al. | Role of 17beta-estradiol and/or progesterone on insulin sensitivity in the rat: implications during pregnancy | |
Wallach et al. | Polycystic ovarian disease: current concepts of pathophysiology and therapy | |
Luttge | Effects of anti-estrogens on testosterone stimulated male sexual behavior and peripheral target tissues in the castrate male rat | |
D'occhio et al. | Effects of androgenic and oestrogenic hormones on mating behaviour in rams castrated before or after puberty | |
Luttge et al. | Stimulation of male and female sexual behavior in gonadectomized rats with estrogen and androgen therapy and its inhibition with concurrent anti-hormone therapy | |
Hillier et al. | Hormonal regulation of preovulatory follicle maturation in the rat | |
Yahr et al. | Aromatization and androgen stimulation of sexual behavior in male and female rats | |
Rissman et al. | Role of androgens in the regulation of sexual behavior in the female musk shrew | |
Baum et al. | Normal differentiation of masculine sexual behavior in male ferrets despite neonatal inhibition of brain aromatase or 5-alpha-reductase activity | |
Alonso et al. | Steroid influences on pineal melatonin production | |
Carmina et al. | Physiological estrogen replacement may enhance the effectiveness of the gonadotropin-releasing hormone agonist in the treatment of hirsutism | |
Guido et al. | Ethinylestradio-Chlormadinone Acetate Combination for the Treatment of Hirsutism and Hormonal Alterations of Normal-Weight Women With Polycystic Ovary Syndrome: Evaluation of the Metabolic Impact | |
Buvat et al. | Hormones, metabolism, aging and men’s health | |
Hoskins et al. | TTHE INHIBITION OF COMB GROWTH IN COCKERELS AND CAPONS BY ESTRONEW | |
Migeon et al. | Adrenal cortex: hypo-and hyperfunction | |
CA2219082A1 (fr) | Utilisation de composes de dihydrotestosterone pour traiter une dysfonction sexuelle chez l'homme | |
Zumpe et al. | Behavioral responses to Depo-Provera, Fadrozole, and estradiol in castrated, testosterone-treated cynomolgus monkeys (Macaca fascicularis): the involvement of progestin receptors | |
Phoenix | Sexual behavior of castrated male rhesus monkeys treated with 19-hydroxytestosterone | |
Lephart et al. | Altered brain and pituitary androgen metabolism by prenatal, perinatal or pre-and postnatal finasteride, flutamide or dihydrotestosterone treatment in juvenile male rats | |
Clemens et al. | Testosterone acts as a prohormone to stimulate male copulatory behavior in male deer mice (Peromyscus maniculatus bairdi). |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |